206 related articles for article (PubMed ID: 17029632)
1. Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck.
Solbach C; Roller M; Eckerdt F; Peters S; Knecht R
BMC Cancer; 2006 Oct; 6():242. PubMed ID: 17029632
[TBL] [Abstract][Full Text] [Related]
2. PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence.
Solbach C; Roller M; Fellbaum C; Nicoletti M; Kaufmann M
Breast; 2004 Feb; 13(1):80-1. PubMed ID: 14759723
[TBL] [Abstract][Full Text] [Related]
3. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma.
Yan S; Zhou C; Lou X; Xiao Z; Zhu H; Wang Q; Wang Y; Lu N; He S; Zhan Q; Liu S; Xu N
Cancer Res; 2009 Apr; 69(8):3283-90. PubMed ID: 19351864
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang J; Yang Y; Chen L; Zheng D; Ma J
Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776
[TBL] [Abstract][Full Text] [Related]
5. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
6. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
8. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
9. Expression of pituitary tumor-transforming gene in endometrial cancer as a prognostic marker.
Kim JW; Song JY; Lee JM; Lee JK; Lee NW; Yeom BW; Lee KW
Int J Gynecol Cancer; 2008; 18(6):1352-9. PubMed ID: 18217976
[TBL] [Abstract][Full Text] [Related]
10. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
11. Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer.
Boelaert K; McCabe CJ; Tannahill LA; Gittoes NJ; Holder RL; Watkinson JC; Bradwell AR; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2003 May; 88(5):2341-7. PubMed ID: 12727994
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA profile in site-specific head and neck squamous cell cancer.
Kalfert D; Pesta M; Kulda V; Topolcan O; Ryska A; Celakovsky P; Laco J; Ludvikova M
Anticancer Res; 2015 Apr; 35(4):2455-63. PubMed ID: 25862914
[TBL] [Abstract][Full Text] [Related]
13. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
16. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
[TBL] [Abstract][Full Text] [Related]
17. The pituitary tumor transforming gene in thyroid cancer.
Lewy GD; Sharma N; Seed RI; Smith VE; Boelaert K; McCabe CJ
J Endocrinol Invest; 2012 Apr; 35(4):425-33. PubMed ID: 22522436
[TBL] [Abstract][Full Text] [Related]
18. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
[TBL] [Abstract][Full Text] [Related]
19. Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence.
Liu X; Feng M; Zhang Y; Dai C; Sun B; Bao X; Deng K; Yao Y; Wang R
World Neurosurg; 2018 May; 113():e213-e221. PubMed ID: 29432944
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
